VEGFR3 Kinase Inhibitor, MAZ51
CAS: 163655-37-6
Ref. 3D-NGA65537
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
- 3-(4-Dimethylamino-Naphthalen-1-Ylmethylene)-1,3-Dihydro-Indol-2-One
MAZ51 is a VEGFR3 kinase inhibitor that binds to the ATP binding site of the VEGFR3 protein. It has been shown to inhibit tumor growth in mouse mammary tumors by inducing cell death and inhibiting angiogenesis. The drug-resistant phenotype was observed in human breast cancer cells with mutations in the VEGFR3 gene, which led to increased expression of the protein. MAZ51 showed potent anti-cancer activity against these cells, but not against other cell lines that were not resistant to paclitaxel. This suggests that MAZ51 may be useful for treating drug-resistant cancers such as those that are resistant to docetaxel.
Propiedades químicas
Consulta técnica sobre: 3D-NGA65537 VEGFR3 Kinase Inhibitor, MAZ51
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
